Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-18

Clinical Trial Update: Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mistletoe extract as treatment for advanced non-small cell lung cancer in patients receiving palliative chemotherapy; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mistletoe extract (Viscum album extract)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN